[English] 日本語
Yorodumi
- PDB-1ter: SOLUTION STRUCTURE OF TERTIAPIN DETERMINED USING NUCLEAR MAGNETIC... -

+
Open data


ID or keywords:

Loading...

-
Basic information

Entry
Database: PDB / ID: 1ter
TitleSOLUTION STRUCTURE OF TERTIAPIN DETERMINED USING NUCLEAR MAGNETIC RESONANCE AND DISTANCE GEOMETRY
ComponentsTERTIAPIN
KeywordsTOXIN
Function / homology: / Tertiapin / Honey bee toxin / host cell presynaptic membrane / potassium channel regulator activity / toxin activity / calmodulin binding / extracellular region / Tertiapin
Function and homology information
Biological speciesApis mellifera (honey bee)
MethodSOLUTION NMR
AuthorsXu, X. / Nelson, J.W.
CitationJournal: Proteins / Year: 1993
Title: Solution structure of tertiapin determined using nuclear magnetic resonance and distance geometry.
Authors: Xu, X. / Nelson, J.W.
History
DepositionApr 8, 1994Processing site: BNL
Revision 1.0Feb 7, 1995Provider: repository / Type: Initial release
Revision 1.1Mar 24, 2008Group: Version format compliance
Revision 1.2Jul 13, 2011Group: Version format compliance
Revision 1.3Nov 29, 2017Group: Derived calculations / Other
Category: pdbx_database_status / pdbx_struct_assembly ...pdbx_database_status / pdbx_struct_assembly / pdbx_struct_oper_list / struct_conf / struct_conf_type
Item: _pdbx_database_status.process_site
Revision 1.4Nov 20, 2024Group: Data collection / Database references ...Data collection / Database references / Derived calculations / Structure summary
Category: chem_comp_atom / chem_comp_bond ...chem_comp_atom / chem_comp_bond / database_2 / pdbx_entry_details / pdbx_modification_feature / struct_conn / struct_site
Item: _database_2.pdbx_DOI / _database_2.pdbx_database_accession ..._database_2.pdbx_DOI / _database_2.pdbx_database_accession / _struct_conn.pdbx_leaving_atom_flag / _struct_site.pdbx_auth_asym_id / _struct_site.pdbx_auth_comp_id / _struct_site.pdbx_auth_seq_id

-
Structure visualization

Structure viewerMolecule:
MolmilJmol/JSmol

Downloads & links

-
Assembly

Deposited unit
A: TERTIAPIN


Theoretical massNumber of molelcules
Total (without water)2,4641
Polymers2,4641
Non-polymers00
Water00
1


  • Idetical with deposited unit
  • defined by author
TypeNameSymmetry operationNumber
identity operation1_5551
Atom site foot note1: LEU 2 - CYS 3 MODEL 1 OMEGA = 218.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
2: ILE 8 - ILE 9 MODEL 1 OMEGA = 142.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
3: PRO 11 - HIS 12 MODEL 1 OMEGA = 225.25 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
4: HIS 12 - MET 13 MODEL 1 OMEGA = 144.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
5: LYS 17 - CYS 18 MODEL 1 OMEGA = 134.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
6: GLY 19 - LYS 20 MODEL 1 OMEGA = 234.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
7: LYS 20 - LYS 21 MODEL 1 OMEGA = 228.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
8: ARG 7 - ILE 8 MODEL 2 OMEGA = 213.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
9: PRO 11 - HIS 12 MODEL 2 OMEGA = 220.06 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
10: HIS 12 - MET 13 MODEL 2 OMEGA = 149.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
11: LYS 17 - CYS 18 MODEL 2 OMEGA = 131.11 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
12: GLY 19 - LYS 20 MODEL 2 OMEGA = 235.15 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
13: LYS 20 - LYS 21 MODEL 2 OMEGA = 231.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
14: LEU 2 - CYS 3 MODEL 3 OMEGA = 221.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
15: ASN 6 - ARG 7 MODEL 3 OMEGA = 148.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
16: ILE 9 - ILE 10 MODEL 3 OMEGA = 214.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
17: PRO 11 - HIS 12 MODEL 3 OMEGA = 227.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
18: HIS 12 - MET 13 MODEL 3 OMEGA = 147.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
19: LYS 17 - CYS 18 MODEL 3 OMEGA = 140.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
20: GLY 19 - LYS 20 MODEL 3 OMEGA = 222.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
21: LEU 2 - CYS 3 MODEL 4 OMEGA = 227.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
22: ASN 6 - ARG 7 MODEL 4 OMEGA = 145.91 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
23: ILE 8 - ILE 9 MODEL 4 OMEGA = 146.70 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
24: PRO 11 - HIS 12 MODEL 4 OMEGA = 225.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
25: HIS 12 - MET 13 MODEL 4 OMEGA = 141.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
26: LYS 17 - CYS 18 MODEL 4 OMEGA = 138.84 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
27: GLY 19 - LYS 20 MODEL 4 OMEGA = 237.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
28: LYS 20 - LYS 21 MODEL 4 OMEGA = 228.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
29: LEU 2 - CYS 3 MODEL 5 OMEGA = 215.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
30: ILE 8 - ILE 9 MODEL 5 OMEGA = 147.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
31: PRO 11 - HIS 12 MODEL 5 OMEGA = 234.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
32: CYS 14 - TRP 15 MODEL 5 OMEGA = 140.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
33: LYS 17 - CYS 18 MODEL 5 OMEGA = 141.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
34: GLY 19 - LYS 20 MODEL 5 OMEGA = 220.82 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
35: LYS 20 - LYS 21 MODEL 5 OMEGA = 148.49 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
36: LEU 2 - CYS 3 MODEL 6 OMEGA = 210.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
37: ASN 6 - ARG 7 MODEL 6 OMEGA = 146.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
38: ILE 8 - ILE 9 MODEL 6 OMEGA = 145.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
39: PRO 11 - HIS 12 MODEL 6 OMEGA = 234.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
40: HIS 12 - MET 13 MODEL 6 OMEGA = 145.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
41: LYS 17 - CYS 18 MODEL 6 OMEGA = 137.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
42: GLY 19 - LYS 20 MODEL 6 OMEGA = 236.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
43: LYS 20 - LYS 21 MODEL 6 OMEGA = 222.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
44: LEU 2 - CYS 3 MODEL 7 OMEGA = 214.71 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
45: ILE 8 - ILE 9 MODEL 7 OMEGA = 144.59 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
46: ILE 9 - ILE 10 MODEL 7 OMEGA = 211.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
47: PRO 11 - HIS 12 MODEL 7 OMEGA = 234.05 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
48: LYS 17 - CYS 18 MODEL 7 OMEGA = 130.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
49: GLY 19 - LYS 20 MODEL 7 OMEGA = 233.32 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
50: LYS 20 - LYS 21 MODEL 7 OMEGA = 240.33 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
51: LEU 2 - CYS 3 MODEL 8 OMEGA = 221.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
52: ASN 6 - ARG 7 MODEL 8 OMEGA = 147.27 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
53: ILE 8 - ILE 9 MODEL 8 OMEGA = 148.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
54: ILE 9 - ILE 10 MODEL 8 OMEGA = 217.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
55: PRO 11 - HIS 12 MODEL 8 OMEGA = 227.96 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
56: HIS 12 - MET 13 MODEL 8 OMEGA = 146.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
57: LYS 17 - CYS 18 MODEL 8 OMEGA = 141.50 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
58: GLY 19 - LYS 20 MODEL 8 OMEGA = 223.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
59: LYS 20 - LYS 21 MODEL 8 OMEGA = 148.56 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
60: LEU 2 - CYS 3 MODEL 9 OMEGA = 220.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
61: ILE 8 - ILE 9 MODEL 9 OMEGA = 143.24 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
62: ILE 9 - ILE 10 MODEL 9 OMEGA = 210.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
63: PRO 11 - HIS 12 MODEL 9 OMEGA = 233.09 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
64: LYS 17 - CYS 18 MODEL 9 OMEGA = 146.14 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
65: GLY 19 - LYS 20 MODEL 9 OMEGA = 240.92 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
66: LYS 20 - LYS 21 MODEL 9 OMEGA = 224.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
67: ARG 7 - ILE 8 MODEL 10 OMEGA = 213.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
68: ILE 9 - ILE 10 MODEL 10 OMEGA = 212.87 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
69: PRO 11 - HIS 12 MODEL 10 OMEGA = 229.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
70: HIS 12 - MET 13 MODEL 10 OMEGA = 142.97 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
71: LYS 17 - CYS 18 MODEL 10 OMEGA = 124.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
72: GLY 19 - LYS 20 MODEL 10 OMEGA = 232.94 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
73: LYS 20 - LYS 21 MODEL 10 OMEGA = 234.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
74: LEU 2 - CYS 3 MODEL 11 OMEGA = 222.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
75: CYS 3 - ASN 4 MODEL 11 OMEGA = 141.80 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
76: ASN 4 - CYS 5 MODEL 11 OMEGA = 148.44 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
77: ASN 6 - ARG 7 MODEL 11 OMEGA = 144.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
78: ILE 10 - PRO 11 MODEL 11 OMEGA = 147.45 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
79: PRO 11 - HIS 12 MODEL 11 OMEGA = 225.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
80: HIS 12 - MET 13 MODEL 11 OMEGA = 143.83 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
81: LYS 17 - CYS 18 MODEL 11 OMEGA = 136.81 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
82: GLY 19 - LYS 20 MODEL 11 OMEGA = 235.29 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
83: LYS 20 - LYS 21 MODEL 11 OMEGA = 231.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
84: LEU 2 - CYS 3 MODEL 12 OMEGA = 210.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
85: ASN 6 - ARG 7 MODEL 12 OMEGA = 146.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
86: ILE 9 - ILE 10 MODEL 12 OMEGA = 210.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
87: PRO 11 - HIS 12 MODEL 12 OMEGA = 234.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
88: HIS 12 - MET 13 MODEL 12 OMEGA = 136.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
89: LYS 17 - CYS 18 MODEL 12 OMEGA = 142.54 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
90: GLY 19 - LYS 20 MODEL 12 OMEGA = 239.93 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
91: LYS 20 - LYS 21 MODEL 12 OMEGA = 223.22 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
92: ASN 6 - ARG 7 MODEL 13 OMEGA = 141.12 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
93: ILE 9 - ILE 10 MODEL 13 OMEGA = 212.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
94: PRO 11 - HIS 12 MODEL 13 OMEGA = 236.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
95: HIS 12 - MET 13 MODEL 13 OMEGA = 132.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
96: LYS 17 - CYS 18 MODEL 13 OMEGA = 132.00 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
97: GLY 19 - LYS 20 MODEL 13 OMEGA = 235.01 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
98: LYS 20 - LYS 21 MODEL 13 OMEGA = 228.08 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
99: ARG 7 - ILE 8 MODEL 14 OMEGA = 211.19 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
100: ILE 10 - PRO 11 MODEL 14 OMEGA = 148.69 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
101: PRO 11 - HIS 12 MODEL 14 OMEGA = 227.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
102: HIS 12 - MET 13 MODEL 14 OMEGA = 140.04 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
103: LYS 17 - CYS 18 MODEL 14 OMEGA = 131.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
104: CYS 18 - GLY 19 MODEL 14 OMEGA = 149.55 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
105: GLY 19 - LYS 20 MODEL 14 OMEGA = 242.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
106: LYS 20 - LYS 21 MODEL 14 OMEGA = 227.21 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
107: ILE 8 - ILE 9 MODEL 15 OMEGA = 144.86 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
108: ILE 9 - ILE 10 MODEL 15 OMEGA = 210.35 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
109: PRO 11 - HIS 12 MODEL 15 OMEGA = 229.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
110: HIS 12 - MET 13 MODEL 15 OMEGA = 146.48 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
111: LYS 17 - CYS 18 MODEL 15 OMEGA = 143.02 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
112: GLY 19 - LYS 20 MODEL 15 OMEGA = 240.39 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
113: LYS 20 - LYS 21 MODEL 15 OMEGA = 221.65 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
114: ILE 9 - ILE 10 MODEL 16 OMEGA = 222.10 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
115: PRO 11 - HIS 12 MODEL 16 OMEGA = 214.72 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
116: LYS 20 - LYS 21 MODEL 16 OMEGA = 149.64 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
117: ILE 9 - ILE 10 MODEL 17 OMEGA = 211.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
118: PRO 11 - HIS 12 MODEL 17 OMEGA = 214.95 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
119: LYS 17 - CYS 18 MODEL 17 OMEGA = 147.52 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
120: LYS 20 - LYS 21 MODEL 17 OMEGA = 148.18 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
121: ILE 9 - ILE 10 MODEL 18 OMEGA = 219.23 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
122: PRO 11 - HIS 12 MODEL 18 OMEGA = 225.88 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
123: LYS 17 - CYS 18 MODEL 18 OMEGA = 147.43 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
124: LYS 20 - LYS 21 MODEL 18 OMEGA = 142.89 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
125: LEU 2 - CYS 3 MODEL 19 OMEGA = 217.40 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
126: ILE 9 - ILE 10 MODEL 19 OMEGA = 221.13 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
127: PRO 11 - HIS 12 MODEL 19 OMEGA = 220.53 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
128: LYS 17 - CYS 18 MODEL 19 OMEGA = 144.20 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
129: LYS 20 - LYS 21 MODEL 19 OMEGA = 216.62 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
130: LEU 2 - CYS 3 MODEL 20 OMEGA = 211.26 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
131: PRO 11 - HIS 12 MODEL 20 OMEGA = 223.98 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
132: LYS 17 - CYS 18 MODEL 20 OMEGA = 141.90 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
133: LYS 20 - LYS 21 MODEL 20 OMEGA = 145.46 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
134: ASN 4 - CYS 5 MODEL 21 OMEGA = 147.77 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
135: ILE 9 - ILE 10 MODEL 21 OMEGA = 214.07 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
136: PRO 11 - HIS 12 MODEL 21 OMEGA = 220.03 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
137: LYS 17 - CYS 18 MODEL 21 OMEGA = 141.79 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
138: LYS 20 - LYS 21 MODEL 21 OMEGA = 135.85 PEPTIDE BOND DEVIATES SIGNIFICANTLY FROM TRANS CONFORMATION
NMR ensembles
DataCriteria
Number of conformers (submitted / calculated)21 / -
Representative

-
Components

#1: Protein/peptide TERTIAPIN


Mass: 2464.141 Da / Num. of mol.: 1
Source method: isolated from a genetically manipulated source
Source: (gene. exp.) Apis mellifera (honey bee) / References: UniProt: P56587
Has protein modificationY

-
Experimental details

-
Experiment

ExperimentMethod: SOLUTION NMR

-
Sample preparation

Crystal grow
*PLUS
Method: other / Details: NMR

-
Processing

NMR ensembleConformers submitted total number: 21

+
About Yorodumi

-
News

-
Feb 9, 2022. New format data for meta-information of EMDB entries

New format data for meta-information of EMDB entries

  • Version 3 of the EMDB header file is now the official format.
  • The previous official version 1.9 will be removed from the archive.

Related info.:EMDB header

External links:wwPDB to switch to version 3 of the EMDB data model

-
Aug 12, 2020. Covid-19 info

Covid-19 info

URL: https://pdbj.org/emnavi/covid19.php

New page: Covid-19 featured information page in EM Navigator.

Related info.:Covid-19 info / Mar 5, 2020. Novel coronavirus structure data

+
Mar 5, 2020. Novel coronavirus structure data

Novel coronavirus structure data

Related info.:Yorodumi Speices / Aug 12, 2020. Covid-19 info

External links:COVID-19 featured content - PDBj / Molecule of the Month (242)：Coronavirus Proteases

+
Jan 31, 2019. EMDB accession codes are about to change! (news from PDBe EMDB page)

EMDB accession codes are about to change! (news from PDBe EMDB page)

  • The allocation of 4 digits for EMDB accession codes will soon come to an end. Whilst these codes will remain in use, new EMDB accession codes will include an additional digit and will expand incrementally as the available range of codes is exhausted. The current 4-digit format prefixed with “EMD-” (i.e. EMD-XXXX) will advance to a 5-digit format (i.e. EMD-XXXXX), and so on. It is currently estimated that the 4-digit codes will be depleted around Spring 2019, at which point the 5-digit format will come into force.
  • The EM Navigator/Yorodumi systems omit the EMD- prefix.

Related info.:Q: What is EMD? / ID/Accession-code notation in Yorodumi/EM Navigator

External links:EMDB Accession Codes are Changing Soon! / Contact to PDBj

+
Jul 12, 2017. Major update of PDB

Major update of PDB

  • wwPDB released updated PDB data conforming to the new PDBx/mmCIF dictionary.
  • This is a major update changing the version number from 4 to 5, and with Remediation, in which all the entries are updated.
  • In this update, many items about electron microscopy experimental information are reorganized (e.g. em_software).
  • Now, EM Navigator and Yorodumi are based on the updated data.

External links:wwPDB Remediation / Enriched Model Files Conforming to OneDep Data Standards Now Available in the PDB FTP Archive

-
Yorodumi

Thousand views of thousand structures

  • Yorodumi is a browser for structure data from EMDB, PDB, SASBDB, etc.
  • This page is also the successor to EM Navigator detail page, and also detail information page/front-end page for Omokage search.
  • The word "yorodu" (or yorozu) is an old Japanese word meaning "ten thousand". "mi" (miru) is to see.

Related info.:EMDB / PDB / SASBDB / Comparison of 3 databanks / Yorodumi Search / Aug 31, 2016. New EM Navigator & Yorodumi / Yorodumi Papers / Jmol/JSmol / Function and homology information / Changes in new EM Navigator and Yorodumi

Read more